Author:
Fuchs Jürgen,Nitschmann Wolfgang,Packer Lester
Reference28 articles.
1. Anderson R, Lukey PT, Dippenaar U, Eftychis HA, Findlay GH, Wooten MW, Nel AE. Dithranol mediates pro-oxidative inhibition of polymorphonuclear leukocyte migration and lymphocyte proliferation. Brit J Dermatol, 117: 405–418, 1987.
2. Ashton RE, Andre P, Lowe NJ, Whitefield M. Anthralin: Historical and current perspectives. J Am Acad Dermatol 9, 173–191, 1983.
3. Auterhof H, Sachdev R. Das Verhalten von Hydroxydianthronderivaten in alkalischem Milieu. Arch Pharm 295, 850–852, 1962.
4. Cavey D, Dickinson RG, Shroot B, Schaefer H. The in vivo fate of topically applied dithranol in the skin of hairless rat. Arzneim Forsch/Drug Res 35, 605–609, 1985.
5. Ducret F, Lamblet P, Löliger J, Savoy MC. Antipsoriatic drug action of anthralin oxidation reactions with peroxidizing lipids. J Free Rad Biol Med 1, 301–306, 1985.